These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31623347)

  • 1. Classic Chromophobe Renal Cell Carcinoma Incur a Larger Number of Chromosomal Losses Than Seen in the Eosinophilic Subtype.
    Ohashi R; Schraml P; Angori S; Batavia AA; Rupp NJ; Ohe C; Otsuki Y; Kawasaki T; Kobayashi H; Kobayashi K; Miyazaki T; Shibuya H; Usuda H; Umezu H; Fujishima F; Furusato B; Osakabe M; Sugai T; Kuroda N; Tsuzuki T; Nagashima Y; Ajioka Y; Moch H
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31623347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Genetic Analysis in Correct Diagnosis of Eosinophilic Variant of Chromophobe Renal Cell Carcinoma.
    Molnar A; Yusenko MV; Kovacs G; Banyai D
    Anticancer Res; 2020 Dec; 40(12):6863-6867. PubMed ID: 33288578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of CDKN1A mRNA and Protein Expression Are Independent Predictors of Poor Outcome in Chromophobe Renal Cell Carcinoma Patients.
    Ohashi R; Angori S; Batavia AA; Rupp NJ; Ajioka Y; Schraml P; Moch H
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32079343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling.
    Liu YJ; Ussakli C; Antic T; Liu Y; Wu Y; True L; Tretiakova MS
    Hum Pathol; 2020 Oct; 104():18-29. PubMed ID: 32673684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Review of Numerical Chromosomal Aberrations in Chromophobe Renal Cell Carcinoma Including Its Variant Morphologies.
    Alaghehbandan R; Trpkov K; Tretiakova M; Luis AS; Rogala JD; Hes O
    Adv Anat Pathol; 2021 Jan; 28(1):8-20. PubMed ID: 33021507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromophobe renal cell carcinoma: Novel molecular insights and clinicopathologic updates.
    Alaghehbandan R; Przybycin CG; Verkarre V; Mehra R
    Asian J Urol; 2022 Jan; 9(1):1-11. PubMed ID: 35198391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant.
    Foix MP; Dunatov A; Martinek P; Mundó EC; Suster S; Sperga M; Lopez JI; Ulamec M; Bulimbasic S; Montiel DP; Alaghehbandan R; Peckova K; Pivovarcikova K; Ondrej D; Rotterova P; Skenderi F; Prochazkova K; Dusek M; Hora M; Michal M; Hes O
    Virchows Arch; 2016 Dec; 469(6):669-678. PubMed ID: 27631338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-β1 expression in chromophobe renal cell carcinoma and renal oncocytoma.
    Demirović A; Cesarec S; Marušić Z; Tomas D; Milošević M; Hudolin T; Krušlin B
    Eur J Histochem; 2014 Jan; 58(1):2265. PubMed ID: 24704995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma.
    Casuscelli J; Weinhold N; Gundem G; Wang L; Zabor EC; Drill E; Wang PI; Nanjangud GJ; Redzematovic A; Nargund AM; Manley BJ; Arcila ME; Donin NM; Cheville JC; Thompson RH; Pantuck AJ; Russo P; Cheng EH; Lee W; Tickoo SK; Ostrovnaya I; Creighton CJ; Papaemmanuil E; Seshan VE; Hakimi AA; Hsieh JJ
    JCI Insight; 2017 Jun; 2(12):. PubMed ID: 28614790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromophobe renal cell carcinoma--chromosomal aberration variability and its relation to Paner grading system: an array CGH and FISH analysis of 37 cases.
    Sperga M; Martinek P; Vanecek T; Grossmann P; Bauleth K; Perez-Montiel D; Alvarado-Cabrero I; Nevidovska K; Lietuvietis V; Hora M; Michal M; Petersson F; Kuroda N; Suster S; Branzovsky J; Hes O
    Virchows Arch; 2013 Oct; 463(4):563-73. PubMed ID: 23913167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LMP2, a novel immunohistochemical marker to distinguish renal oncocytoma from the eosinophilic variant of chromophobe renal cell carcinoma.
    Zheng G; Chaux A; Sharma R; Netto G; Caturegli P
    Exp Mol Pathol; 2013 Feb; 94(1):29-32. PubMed ID: 22705098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NKX6-1 Is a Less Sensitive But Specific Biomarker of Chromophobe Renal Cell Carcinoma.
    Xie B; Tong K; Yang J; Wang T; Cheng L; Zeng S; Hu Z
    Am J Surg Pathol; 2022 Jun; 46(6):809-815. PubMed ID: 35256556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Utility of ERBB4 and RB1 Immunohistochemistry in Distinguishing Chromophobe Renal Cell Carcinoma From Renal Oncocytoma.
    Sun T; Hutchinson L; Zhou AG; Liu Q; Cosar EF; St Cyr M; Ninteau N; Dresser K; Cheng L; Jiang Z; Cornejo KM
    Int J Surg Pathol; 2020 May; 28(3):259-264. PubMed ID: 31640438
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic Profiling Uncovers Genome-Wide Loss of Heterozygosity and Provides Insight into Mechanisms of Sarcomatoid Transformation in Chromophobe Renal Cell Carcinoma.
    Collins K; Acosta AM; Siegmund SE; Cheng L; Hirsch MS; Idrees MT
    Mod Pathol; 2024 Feb; 37(2):100396. PubMed ID: 38043790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allele Loss and Reduced Expression of CYCLOPS Genes is a Characteristic Feature of Chromophobe Renal Cell Carcinoma.
    Ohashi R; Schraml P; Batavia A; Angori S; Simmler P; Rupp N; Ajioka Y; Oliva E; Moch H
    Transl Oncol; 2019 Sep; 12(9):1131-1137. PubMed ID: 31200327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic diversity in chromophobe renal cell carcinoma does not impact survival outcome: A comparative international multi-institutional study.
    Kolar J; Llaurado AF; Ulamec M; Skenderi F; Perez-Montiel D; Alvarado-Cabrero I; Bulimbasic S; Sperga M; Tretiakova M; Osunkoya AO; Rogala J; Comperat E; Gal V; Dunatov A; Pivovarcikova K; Michalova K; Vesela AB; Slisarenko M; Strakova AP; Pitra T; Hora M; Michal M; Alaghehbandan R; Hes O
    Ann Diagn Pathol; 2022 Oct; 60():151978. PubMed ID: 35609473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of tetraploidization in chromophobe renal cell carcinoma: Insights and pitfalls.
    Di Mauro I; Ambrosetti D; Vignot L; Roussel JF; Dadone-Montaudie B; Peyron AC; Quintens H; Durand M; Amiel J; Pedeutour F
    Genes Chromosomes Cancer; 2020 Jul; ():. PubMed ID: 32658344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-Generation Sequencing to Detect Deletion of RB1 and ERBB4 Genes in Chromophobe Renal Cell Carcinoma: A Potential Role in Distinguishing Chromophobe Renal Cell Carcinoma from Renal Oncocytoma.
    Liu Q; Cornejo KM; Cheng L; Hutchinson L; Wang M; Zhang S; Tomaszewicz K; Cosar EF; Woda BA; Jiang Z
    Am J Pathol; 2018 Apr; 188(4):846-852. PubMed ID: 29353061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications.
    Linehan WM; Ricketts CJ
    Nat Rev Urol; 2019 Sep; 16(9):539-552. PubMed ID: 31278395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.